Energy-efficient and Health Promoting Light for Elderly People
NCT ID: NCT02216318
Last Updated: 2018-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2013-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms
NCT03758768
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
NCT01586039
Light Exposure to Treat Sleep Disruption in Older People
NCT00427323
Study of Effects of Light on the Vigilance and Cognitive Performance Following a Night Without Sleep
NCT02478528
Benefits and Risks of Artificial Light Exposure: Characterisation of Effects on Alertness, Sleep, Cognitive Performance, Mood and Biological Rhythms
NCT05232383
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Based on previous research, blue light early in the day and abscence of blue light during evening is important for the entrainment.
In this study, lightning conditions in the home of healthy subjects are set to either blue enriched or red enriched from 8 a.m to 1. p.m. The lightning condition is based on a randomization protocol in a cross-over study for 3 weeks in each condition, separated by a one week pause.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
red light
red light during the whole day
blue light
Blue light
Blue light during early day
blue light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blue light
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elforsk
UNKNOWN
Albertslund Kommune
UNKNOWN
Gate 21
UNKNOWN
DTU Fotonik
UNKNOWN
VISO systems
UNKNOWN
AF Lightning
UNKNOWN
Philips Healthcare
INDUSTRY
Statens Byggeforskningsinstitut
UNKNOWN
Glostrup University Hospital, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Line Kessel
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Line Kessel, MD
Role: PRINCIPAL_INVESTIGATOR
Glostrup University Hospital, Copenhagen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-3-2013-085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.